Many everyday foods and seasonings—such as herbs, spices, and aromatic plants—contain natural compounds called phytochemicals that can regulate inflammatory pathways. For centuries, these ingredients ...

Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...

An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.

Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our ...

To improve safety and operational efficiency, the Railways has approved the implementation of Electronic Interlocking (EI) at 34 stations on the Northern Railway route where the Kavach system is being ...

Drinking hot water can help you stay hydrated, and it may come with added health benefits like improving digestion or ...

Scotland for Nuclear Energy said the country could miss out on jobs and economic growth if it does not add nuclear to the ...

An agreement on the third implementation phase of Destination Earth (DestinE), the European Commission's initiative to develop a highly accurate digital twin of Earth, has been signed between the ...

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

Please provide your email address to receive an email when new articles are posted on . A protein known as granzyme K was recently shown to be a driver of inflammation by activating the complement ...

Your nervous system is a network that sends signals between your brain and other parts of your body to control your body's movements and processes. This system includes your brain, spinal cord, and ...

Basel, August 8, 2024 – Novartis today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta ® (iptacopan), a first-in-class complement inhibitor for ...